Pediatric Type 1 diabetes screening recommendations

An international team of experts has published a consensus paper in the journal ‘Diabetologia’ recommending systematic, population-wide screening for Type 1 diabetes in children. The proposed strategy aims to identify the disease via islet autoantibodies in the blood before clinical symptoms manifest, potentially reducing the risk of severe complications like diabetic ketoacidosis.

The recommended model suggests a staggered testing approach for children, beginning between ages two and four, with follow-up assessments at ages six to eight and again between ages 10 and 15. Proponents argue that early detection facilitates timely outpatient insulin treatment and the use of disease-modifying therapies to delay clinical onset.

Despite these recommendations, the proposal has met with skepticism. The German Diabetes Society (DDG) has stated it does not currently see a basis for population-wide screening, noting that the disease cannot be prevented even with early detection. Critics have also raised concerns regarding the cost-benefit ratio and the psychological burden placed on families who must manage the uncertainty of when a child might fall ill.